RGS5 (regulator of G protein signaling 5)

2007-04-01  

Identity

HGNC
LOCATION
1q23.3
LOCUSID
ALIAS
MST092,MST106,MST129,MSTP032,MSTP092,MSTP106,MSTP129
FUSION GENES

Other Information

Locus ID:

NCBI: 8490
MIM: 603276
HGNC: 10001
Ensembl: ENSG00000232995

Variants:

dbSNP: 8490
ClinVar: 8490
TCGA: ENSG00000232995
COSMIC: RGS5

RNA/Proteins

Expression (GTEx)

0
1
2
3
4

Pathways

PathwaySourceExternal ID
Signal TransductionREACTOMER-HSA-162582
Signaling by GPCRREACTOMER-HSA-372790
GPCR downstream signalingREACTOMER-HSA-388396
G alpha (i) signalling eventsREACTOMER-HSA-418594

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA128406956fluorouracilChemicalClinicalAnnotationassociatedPD25069475
PA130232992bevacizumabChemicalClinicalAnnotationassociatedPD25069475
PA446108Colorectal NeoplasmsDiseaseClinicalAnnotationassociatedPD25069475
PA450085irinotecanChemicalClinicalAnnotationassociatedPD25069475
PA450198leucovorinChemicalClinicalAnnotationassociatedPD25069475

References

Pubmed IDYearTitleCitations
375941342023Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation.1
375941342023Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation.1
356811352022Implications of regulator of G-protein signaling 5 expression in the pathogenesis of primary and secondary hyperparathyroidism.0
361115492022RGS5: a novel role as a hypoxia-responsive protein that suppresses chemokinetic and chemotactic migration in brain pericytes.7
356811352022Implications of regulator of G-protein signaling 5 expression in the pathogenesis of primary and secondary hyperparathyroidism.0
361115492022RGS5: a novel role as a hypoxia-responsive protein that suppresses chemokinetic and chemotactic migration in brain pericytes.7
316051222021Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.10
321913452021Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.33
342125342021Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma.4
343599182021RGS5 Attenuates Baseline Activity of ERK1/2 and Promotes Growth Arrest of Vascular Smooth Muscle Cells.5
316051222021Down-regulated RGS5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease.10
321913452021Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.33
342125342021Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma.4
343599182021RGS5 Attenuates Baseline Activity of ERK1/2 and Promotes Growth Arrest of Vascular Smooth Muscle Cells.5
320419702020Human cytomegalovirus promoting endothelial cell proliferation by targeting regulator of G-protein signaling 5 hypermethylation and downregulation.3

Citation

Dessen P

RGS5 (regulator of G protein signaling 5)

Atlas Genet Cytogenet Oncol Haematol. 2007-04-01

Online version: http://atlasgeneticsoncology.org/gene/46825/rgs5-(regulator-of-g-protein-signaling-5)